D. E. Shaw & Co., Inc. Avanos Medical, Inc. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,191,922 shares of AVNS stock, worth $14.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,191,922

Previous 1,088,975 9.45%

Holding current value

$14.1 Million

Previous $15.6 Million 6.51%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$12.03 - $14.52 $1.24 Million - $1.49 Million	102,947 Added 9.45%	1,191,922 $14.6 Million
Q1 2025 May 15, 2025	BUY	$13.95 - $17.45 $8.29 Million - $10.4 Million	594,348 Added 120.16%	1,088,975 $15.6 Million
Q4 2024 Feb 14, 2025	BUY	$15.58 - $23.61 $2.32 Million - $3.52 Million	148,902 Added 43.07%	494,627 $7.87 Million
Q3 2024 Nov 14, 2024	SELL	$19.21 - $24.69 $2.71 Million - $3.48 Million	-140,822 Reduced 28.94%	345,725 $8.31 Million
Q2 2024 Aug 14, 2024	BUY	$17.85 - $20.42 $1.33 Million - $1.53 Million	74,767 Added 18.16%	486,547 $9.69 Million
Q1 2024 May 15, 2024	BUY	$17.97 - $22.68 $1.4 Million - $1.76 Million	77,663 Added 23.24%	411,780 $8.2 Million
Q4 2023 Feb 14, 2024	SELL	$17.64 - $22.99 $776,089 - $1.01 Million	-43,996 Reduced 11.64%	334,117 $7.49 Million
Q3 2023 Nov 14, 2023	BUY	$19.93 - $26.31 $170,361 - $224,897	8,548 Added 2.31%	378,113 $7.65 Million
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $3.33 Million - $4.58 Million	-147,816 Reduced 28.57%	369,565 $9.45 Million
Q1 2023 May 15, 2023	SELL	$26.92 - $31.75 $2.66 Million - $3.13 Million	-98,641 Reduced 16.01%	517,381 $15.4 Million
Q4 2022 Feb 14, 2023	SELL	$19.88 - $27.37 $2.05 Million - $2.82 Million	-102,999 Reduced 14.32%	616,022 $16.7 Million
Q3 2022 Nov 14, 2022	SELL	$21.56 - $29.59 $1.33 Million - $1.82 Million	-61,613 Reduced 7.89%	719,021 $15.7 Million
Q2 2022 Aug 15, 2022	SELL	$24.87 - $34.68 $2.91 Million - $4.05 Million	-116,815 Reduced 13.02%	780,634 $21.3 Million
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $3.59 Million - $4.44 Million	124,254 Added 16.07%	897,449 $30.1 Million
Q4 2021 Feb 14, 2022	BUY	$29.25 - $36.02 $2.08 Million - $2.56 Million	70,960 Added 10.1%	773,195 $26.8 Million
Q3 2021 Nov 15, 2021	BUY	$31.2 - $38.5 $5.85 Million - $7.22 Million	187,548 Added 36.44%	702,235 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$36.37 - $45.72 $11.6 Million - $14.6 Million	320,127 Added 164.54%	514,687 $18.7 Million
Q1 2021 May 17, 2021	BUY	$43.5 - $53.4 $1.11 Million - $1.37 Million	25,620 Added 15.17%	194,560 $8.51 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $49.5 $2.47 Million - $3.69 Million	-74,638 Reduced 30.64%	168,940 $7.75 Million
Q3 2020 Nov 16, 2020	SELL	$28.67 - $34.32 $1.71 Million - $2.05 Million	-59,790 Reduced 19.71%	243,578 $8.09 Million
Q2 2020 Aug 14, 2020	BUY	$23.48 - $33.86 $1.6 Million - $2.31 Million	68,287 Added 29.05%	303,368 $8.92 Million
Q1 2020 May 15, 2020	BUY	$20.64 - $34.41 $2.97 Million - $4.96 Million	144,048 Added 158.24%	235,081 $6.33 Million
Q4 2019 Feb 14, 2020	SELL	$31.89 - $47.34 $5.37 Million - $7.98 Million	-168,543 Reduced 64.93%	91,033 $3.07 Million
Q3 2019 Nov 14, 2019	BUY	$32.06 - $44.0 $584,710 - $802,472	18,238 Added 7.56%	259,576 $9.72 Million
Q2 2019 Aug 14, 2019	SELL	$37.68 - $46.52 $5.51 Million - $6.8 Million	-146,265 Reduced 37.74%	241,338 $10.5 Million
Q1 2019 May 15, 2019	BUY	$39.84 - $51.04 $1.65 Million - $2.12 Million	41,508 Added 11.99%	387,603 $16.5 Million
Q4 2018 Feb 14, 2019	BUY	$41.16 - $66.67 $11.5 Million - $18.6 Million	279,054 Added 416.24%	346,095 $15.5 Million
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $3.7 Million - $4.87 Million	67,041 New	67,041 $4.59 Million

Others Institutions Holding AVNS

# of Institutions

311

Shares Held

44.5M

Call Options Held

Put Options Held

21.8K

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $551M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account